CLINICAL_TRIALS
trial_result
· 2024-02-14
Clinical Trial Update: Ketamine Pilot Study [Phase 4]
Summary
A Phase 4 pilot study investigating ketamine for rattlesnake envenomation was terminated, with results posted in 2024.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Meghan Spyres | Conditions: Rattlesnake Envenomation | Phase 4 | Status: TERMINATED | Results posted: 2024-02-14